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The RNA-dependent RNA-polymerase, 3D
pol, is an essential component in the picornavirus genome for the replication of single
stranded RNA. However, transgenic expression of 3D
pol in mice has antiviral eﬀects. Here, we discuss the structure and function
of 3D
pol during picornavirus replication, we review the evidence and consequence of a host immune response to epitopes
in 3D
pol after picornavirus infection, highlight data showing the antiviral eﬀects of transgenic 3D
pol from Theiler’s murine
encephalomyelitis virus (TMEV), and discuss potential mechanisms by which 3D
pol is causing this antiviral eﬀect in mice.
1.Introduction
Picornavirusesaremembersofalargefamilyofviruseswhich
are classiﬁed into twelve diﬀerent genera. These viruses can
cause acute illness as benign as the common cold to chronic
illness like poliomyelitis in humans, and foot and mouth
disease in split-hoofed animals. Picornavirus was derived
from the word “pico” meaning small and “rna” for the single
stranded ribonucleic acid it contains. The RNA genomes
of picornaviruses are positive sense and can range between
6.7 to 9.5 kilobases. Picornaviral virions are nonenveloped,
however, the RNA genome is encapsulated in an icosahedral
proteinstructuremadefromfourcapsidproteinsencodedby
the virus.
The single positive-stranded RNA genome of the virus
is translated into a single polyprotein which is divided into
three regions P1, P2, and P3 (Figure 1). P1 encodes proteins
that make up the viral capsid (consisting of VP1, VP2,
VP3, and VP4), whereas the P2 and P3 regions encode
proteins that are involved in protein processing and genome
replication. Cleavage of the polyprotein is carried out by
proteinase 2Apro,3 C pro,o r3 C D pro.3 C D pro can then be
cleaved further into 3Cpro and 3Dpol. The fourth and ﬁnal
p r o t e i nd o m a i no ft h eP 3r e gi o ni s3 D pol,a nR N A - d e pe n d e n t
RNA-polymerase which drives replication of both plus and
minusstrandedviralRNAandisthemainfocusofthispaper.
3Dpol was ﬁrst characterized from experiments which
used cell lysates from polio-infected cells to denote RNA
polymerase activity using radioactive nucleotide incorpo-
ration into viral RNA [1]. 3Dpol associates with cellular
membranefractionsinacomplexofviralproteinsthatforms
the RNA replication complex in which 3Dpol is the major
component [2]. 3Dpol later was found to be a template and
primerdependentenzyme,whenrecombinant3Dpol puriﬁed
frombacteriacouldcopypoliovirusRNAinacell-freesystem
only in the presence of an oligo (U) primer [3, 4].
This paper will focus on RNA-dependent RNA-
polymerase, 3Dpol, and recently published data which
shows that transgenically expressed 3Dpol from Theiler’s
murine encephalomyelitis virus (TMEV) inhibits viral
replication and subsequent infection [5]. This eﬀect appears
to be broader than inhibiting TMEV as we will show data
of the antiviral eﬀect of 3D using another picornavirus
and a nonpicornavirus infection in mice. We will ﬁrst
review the sequence and structural homologies of the 3D
polymerase between diﬀerent viruses in the picornavirus
family. Secondly, we will review host immune recognition of
3D in mice and contrast this to other picornavirus proteins.
Finally, we will review our recently published data and new
data showing the antiviral eﬀect of transgenic 3D and discuss
potential mechanisms of how 3D polymerase is causing this
antiviral eﬀect.2 Advances in Virology
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Figure 1: Genomic organization of picornaviruses with the covalently linked VPg peptide as it is packaged in the virion. The regions of the
P1 (pink), P2 (blue), and P3 (brown) are shown along with the viral proteins encoded within each domain. P1 encodes capsid proteins and
the P2 and P3 domains encode noncapsid proteins used for protein processing and replication. The plus-sense single stranded RNA genome
is translated into a single polyprotein and then cleaved by cis and transacting viral proteases.
Table 1: Amino acid sequence alignment of 3Dpol from ﬁve diﬀerent picornaviruses to TMEV 3Dpol (Swiss Prot Accession: P13899) which
wasusedforthequerysequence.ThesequencealignmentwasrunusingBlastpfromNationalCenterforBiotechnologyInformation(NCBI)
web site for 2 or more sequences [6, 7]. Column heading deﬁnitions: Accession = the accession # from the Swiss Prot database of the aligned
sequence. Identities = percentage of amino acids that are identical to the query in the alignment. Positives = the percentage of amino acid
that have similar physical properties to the query in the alignment. Gaps = percentage of amino acids that create a gap to the query in the
alignment. Score = Bit score. This is derived from the raw alignment score in which the statistical properties of the scoring system used have
been taken into account. Because bit scores have been normalized with respect to the scoring system, they are used to compare alignment
scores from diﬀerent searches. E value = Expectation value. The number of diﬀerent alignments with scores equivalent to or better than this
alignment that are expected to occur in a database search by chance. Hence, the lower the E value, the more signiﬁcant the score.
Accession Identities Positives Gaps Score (Bits) E value
EMCV P3304 65 78 0 627 0.E +00
FMDV P3305 41 62 2 370 3.E −106
HRV P3303 32 53 5 237 4.E −66
PV P3300 31 52 6 234 2.E −65
EV71 Q66478 29 50 4 207 4.E −57
2. Structure and Function of 3Dpol
Althoughtheoverallaminoacidsequencesof3Dpolymerase
between diﬀerent picornaviruses are not very homologous,
the basic overall structure and binding motifs between them
areverysimilar(Table 1 ).Crystalstructuresfrompoliovirus,
rhinovirus, and foot and mouth disease virus polymerases
showed resolution of all amino acids in 3Dpol and showed
that the enzyme has the same overall structure as other DNA
and RNA polymerases in that it contains ﬁnger, palm, and
thumb domains [8–11]( Figure 2). Four motifs in the palm
are identical to all other RNA polymerases, and the ﬁfth
domain is similar to other RNA dependent, but not DNA
dependent polymerases [9, 12, 13]. Furthermore, the amino
acid sequence residing in these motifs are highly conserved
betweendiﬀerentpicornaviruses[14].Theaminoacidsatthe
N-terminus of 3D polymerase were found to be important
in the function of this enzyme. The N-termunis encirclesAdvances in Virology 3
the active site in the palm domain and mutations in the
N-termunis have been shown to disrupt 3D polymerase
activity [8, 11, 15]. More recently, a coxsackievirus 3D
polymerase demonstrated the importance of hydrophobicity
at residue 5 where the polymerase was more active with
amino acids which were more hydrophobic at this residue
[16]. This is important for stabilizing the structure of 3D
duringaconformationalchangethatoccursatthenucleotide
repositioning step.
In 1995, eﬃcient polymerization by poliovirus 3D
polymerase was found to be concentration dependent,
and chemical cross-linking of proteins after initiation of
elongation found many polymerase-polymerase interactions
[17]. Later the ﬁrst crystal structure of 3D polymerase found
many intermolecular interactions important in polymerase
function [9]. The polymerase has two interfaces which
allows each molecule to form a head to tail conﬁguration
and oligomerize [9]. Interface I involves interactions with
residues on the back side of the thumb with residues on the
back of the palm to align each molecule head to tail to form
long ﬁbers. Interface II involves intermolecular donation of
the NH2-terminus from one molecule to the thumb region
ofanotherpolymerasemoleculeforminganotherheadtotail
oriented ﬁber strand. The ﬁbers formed from both interface
I and interface II interactions intersect each other at a 90-
degree angle to form a two-dimensional array. This 3D
polymerase lattice was visualized on membranous vesicles
in poliovirus-infected cells by electron microscopy [18].
However, the function of this lattice is not known, nor is it
known whether this same lattice occurs in all picornaviruses
expressing 3D polymerase. A virus containing mutations
to amino acids Arg-455 and Arg-456 in the back of the
thumb disrupted the formation of polymerase ﬁbers and the
virus was not viable, however, the lack of viral replication
from these mutations was the result of a disruption in
the interaction of 3D with the 3C domain. Furthermore,
mutations to residues Asp-339, Ser-341, and Asp-349 in
the palm domain also disrupted the formation of ﬁbers,
and despite reduced replication the virus remained viable.
This indicated that the formation of ﬁbers along interface
Ii sn o te s s e n t i a lf o rv i r u sv i a b i l i t y[ 19]. Although these
intermolecular interactions may not be essential for viral
replication and viability, they are important for eﬃcient
replication of virus as discovered by biochemical assays using
mutated polymerases [20].
3D polymerase not only interacts with itself but also
forms molecular interactions with other viral molecules
during genomic replication. The chronological sequence of
steps and the molecular interaction that occurs during viral
replication is not completely understood and varies slightly
among diﬀerent picornaviruses. However, all picornaviruses
have the peptide, VPg, covalently linked to the 5  end of
their genome. VPg is a 22 amino acid peptide derived from
the 3B portion of 3AB and serves as a primer for 3Dpol
after VPg is uridylylated to form VPg-pUpU. The process
of VPg uridylylation and initiation of replication of 3Dpol
takes place in a complex of viral RNA proteins that reside
onmembranousvesiclescalledtheRNAreplicationcomplex.
The RNA replication complex in picornaviruses sequester
Fingers
Palm
Thumb
Figure 2: Crystal structure of 3D polymerase from FMDV in
the “right-handed” conﬁguration typical of polymerases showing
ﬁngers (red), palm (green), and thumb (blue) domains [8].
Structure was obtained from the molecular modeling database
(MMDB ID: 29094) at the NCBI web site and illustrated using
Cn3D [34, 35].
viral replication components in a localized area to increase
the eﬃciency of RNA replication [21]. Many studies have
determined what viral and host proteins are involved in
VPg uridylylation and initiation of RNA replication. In this
replication complex, 3AB resides in the lipid bilayer of the
membranous vesicles. Fluorescent membrane topography
studiesinmodel membranevesiclesshowedthatmembrane-
bound 3AB is highly eﬃcient in stimulating 3D polymerase
activity, in contrast to 3A alone [21]. This same study
showed that the release of VPg by cleavage of 3AB with
proteinase 3CD could be uridylylated. Residues important in
the interaction and recruitment of the 3D subunit to 3AB
take place through the binding of the B subunit (VPg) in
3AB and the base of the thumb in the 3D subunit [22, 23].
This interaction recruits 3CD dimers and/or 3D itself, as
3CD dimers are important to the recruitment of mature 3D
polymerase to the replication complex through interactions
witharegionof3Candaminoacidsinthebackofthethumb
in 3D polymerase [24,25]. The“sea”of 3AB moleculesin the
membrane serves as the source of VPg after the membranous
3AB is cleaved by the recruited 3CD protease [26]. 3AB is
not the only precursor protein that may be a donor for VPg.
A mutant poliovirus which introduced a defective cleavage
site between 3B and 3C, replicated and produced 3BC-linked
RNA [27, 28]. Also, an in vitro uridylylation assay using
a 15-nucleotide RNA template and poliovirus polymerase
revealed that 3D can uridylylate other 3D molecules as well
as viral 3CD and 3AB precursors [29]. After being cleaved,
VPg interacts with 3D polymerase through residues in the
pocket of the palm [8, 30]. VPg bound to 3Dpol is then
uridylylated using a cis acting replication element located
in the open reading frame of picornaviruses as a template
via a “slide back” mechanism [31]. After the uridylylation of
VPg, VPg-pUpU translocates to the 3  end of negative sense
strands where it serves as a primer for 3D polymerization in
the initiation of positive stranded RNA synthesis. Negative
stranded synthesis is initiated by a diﬀerent mechanism as
mutations to cre that block Vpg uridylylation at this site do
not eﬀect synthesis of negative stranded RNA [32, 33].4 Advances in Virology
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Figure 3: Viral transcripts and demyelination in mice infected with TMEV. (a) Nontransgenic and 3D transgenic mice were infected with
2×105 plaque forming units of TMEV intracerebrally. Brain and spinal cord were harvested after 7 and 180 days and total RNA was isolated
using Trizol reagent (Invitrogen). Viral transcripts for TMEV were quantiﬁed by real-time RT-PCR using primers speciﬁc for the VP2 region
of TMEV. Data are expressed as mean relative viral transcripts + SEM (n = 5 for nontransgenic and 5 for 3D transgenic) in the brain or
spinal cord above uninfected mice and were normalized to GAPDH. (b) Percent of spinal cord quadrants containing demyelinated lesions
in 3D transgenic and nontransgenic FVB mice at 270 days after infection. Statistical signiﬁcance was determined using the Mann-Whitney
rank sum test.
3. Host ImmuneResponse to 3Dpol
Until recently, T and B cell-speciﬁc responses to 3D poly-
meraseinpicornaviralinfectionshadnotbeencharacterized.
Numerous studies have been done to elicit which viral
peptides are recognized by the adaptive immune system,
however, most of the peptides important in viral clearance
were found to be capsid proteins. Although there are many
picornaviruses which may elicit a 3D speciﬁc immune
response, we will focus on the TO subgroup of TMEV
becauseimmuneresponsestothissubgrouphasbeenstudied
in depth as cerebral infection with this subgroup of TMEV
is used in mouse models for demyelinating diseases such
a multiple sclerosis in mouse strains that are susceptible
to a persistent viral infection in the spinal cord. There are
also mice resistant to persistent TMEV infection. Resistant
mice have similar acute viral encephalitis in the brain after
intracerebral infection, however, the virus is then cleared
from the CNS. Using susceptible and resistant mouse strains
the genetic factors associated with viral susceptibility map
to the H-2D locus of the class I major histocompatability
complex [36–38]. Mice containing the H-2b,d,k haplotypes
are resistant to persistent infection whereas H-2f,p,q,r,s,v
haplotypes are susceptible. Clearance of the virus from
the CNS in resistant haplotypes is dependent on a class I
restricted CD8+ cytotoxic T lymphocyte (CTL) response,
because normally resistant mice that are depleted of CD8+
T cells or lack the expression of beta 2 microglobulin (b2M)
become susceptible to persistent viral infection [39–41].
After it was determined that a class I restricted CTL
response was important for viral clearance of TMEV in
mice, studies were done to ﬁnd the viral antigens which
were recognized by CTL’s. It was shown that capsid proteins
expressed transgenically in mice with a genetically resistantAdvances in Virology 5
background became susceptible to persistent TMEV infec-
tion, in contrast to mice that expressed noncapsid proteins
such as the 3D polymerase [42]. Later it was found that
the peptide VP2121–130 was the immunodominant peptide
conferring resistance in mice expressing H-2Db [43].
Although class I restricted CTL responses to viral capsid
antigens determines whether mice clear TMEV, class II
responses to viral antigens also occur and play a role in
CNS injury in the absence of a strong CTL response [44].
Recently SJL mice were found to have a dominant CD4+
T-cell response to a peptide epitope in 3D polymerase
[45]. 3D peptide-speciﬁc CD4+ T cells were found in both
SJL and B6 mice after infection with TMEV, with the
susceptible SJL mice containing more 3D speciﬁc T cells
than the resistant B6 mice. Furthermore, it was determined
through preimmunization and tolerization of mice, that
CD4+ T cells speciﬁc to the peptide epitope 3D21–36 play
a more pathogenic role in susceptible SJL mice than CD4+
T cells speciﬁc to the capsid epitopes (VP1233–250,V P 2 74–86,
VP324–37), because deletion of 3D21–36 peptide speciﬁc T cells
reduced demyelination and clinical scores in SJL mice.
Of interest, CD4+ T cells can be pathogenic or protective
depending on the viral epitope. The most important factor
in viral clearance is restricted to strong CD8+ CTL response
to viral capsid antigens. However, in the absence of a strong
CTL response the viral antigen for which the majority of
CD4+ Tc e l l sa r es p e c i ﬁ ct om a yh a v eam a j o ri n ﬂ u e n c eo n
the severity of disease in a persistent viral infection. Because
the available T-cell repertoire in the periphery is dependent
on the mouse haplotype, mice with susceptible haplotypes
may have diﬀerent numbers of 3D21–36 speciﬁc CD4+ T
cells in there repertoire, contributing to diﬀerent degrees of
injury. It is not known why 3D21–36 speciﬁc T cells are more
pathogenic, but it could be that 3D21–36 CD4+ T cells are
only weakly stimulated by these epitopes. This would then
lead to weak recruitment of other immune cells to the area
of infection resulting in nonclearance and ongoing persistent
infectionthatsmoldersanddamagesnearbycellsintheCNS.
4.3D asanAntiviralMolecule
Since3Dpolymeraseplayssuchacentralroleinpicornavirus
replication many strategies have been devised to inhibit
the function of 3D and ultimately slow the replication of
picornaviruses. One such strategy is the use of nucleoside
analogs, such as ribavirin which increases the error rate of
the already low ﬁdelity 3D polymerase into a state of lethal
mutagenesis.However,therearefrequentside eﬀectsbecause
most nucleoside analogs also incorporate into host cell RNA.
Also, the virus becomes resistant to treatment. The idea that
3D polymerase is a target for antiviral therapy is logical
because proper function of 3D is required for picornaviral
replication. However, transgenic expression of 3D having
antiviral properties is not as easily explained. Our published
data is the ﬁrst using transgenic 3D mice to show antiviral
eﬀects. We originally made 3D transgenic mice to be used as
a control transgene to study the eﬀects of tolerance to other
picornaviral proteins (VP1, VP2, VP3, etc.). At that time,
3D was not thought to be an important antigen for T cells
involved in viral clearance. However, after quantifying viral
transcripts in 3D transgenic mice we noticed these mice had
100 to 1000 fold reductions in viral RNA after intracranial
infection with TMEV compared to nontransgenic mice or
transgenic mice expressing other viral capsid proteins. For
this reason, the mechanism behind the antiviral eﬀect of
transgenic 3D may producean“outside the box” explanation
that will open new avenues for the way scientists think about
antiviral research.
FVB mice were made transgenic by microinjection of a
linearized vector with the coding region of 3D polymerase
from the DA strain of TMEV containing a C-terminus
histidine tag. A human ubiquitin promoter was placed
upstream of the 3D gene for constitutive expression of 3D in
all tissues. We demonstrated that 3D transcripts were present
in all tissues examined. The amount of 3D transcripts varied
in each tissue with the CNS showing the highest 3D tran-
script levels. After intracranial infection with TMEV, viral
infection was inhibited in these mice compared to infected
nontransgenic FVB mice and the virus was cleared after the
acute phase of the infection. This led to decreased brain and
spinal cord pathology and consequently the preservation of
neurons and function in mice containing the 3D transgene.
Transgenic mice expressing 3D had less viral transcripts
in the spinal cord at both 7 and 180 days after infection
with TMEV than nontransgenic control mice (Figure 3(a)).
Because of the antiviral eﬀects of the 3D transgene these
mice controlled the virus by 180 days as no detectable viral
transcripts were present at this time point whereas the virus
persisted in the spinal cord of nontransgenic mice. This
reduction in viral load caused less demyelination in 3D
transgenic mice at 270 days postinfection (Figure 3(b)).
After studying the eﬀects of 3D in FVB mice that are
susceptible to persistent TMEV infection, we crossed them
to FVB mice that contained the H-2Db transgene (FVB-
Db mice). T cells in FVB-Db m i c er e s p o n db e t t e rt oT M E V
infection and clear the virus making these mice resistant to
persistent infection of the spinal cord. Because these mice
have a diﬀerent T-cell repertoire, containing H-2Db speciﬁc
T cells, than the wild-type FVB mice which contain a T-cell
repertoire that only recognizes the H-2q class I molecules,
wecouldtestwhetherthe3Dtransgenewouldfurtherinhibit
infectioninmiceofadiﬀerenthaplotype.Ifthe3Dtransgene
failed to have an antiviral eﬀect in FVB-Db mice it would
have suggested that transgenic 3D expression may be acting
through the adaptive immune system because FVB-Db mice
already eﬃciently clear the virus, therefore the eﬀect of 3D
would be lost in the background. However FVB-Db mice
containing the 3D transgene showed decreased viral loads
during the acute phase of the infection. Viral transcripts in
the spinal cord were signiﬁcantly reduced in FVB-Db mice
containing the 3D transgene versus nontransgenic FVB-Db
mice at 7 days (Figure 3(a)). These observations led us to
hypothesize that transgenic 3D is not altering the adaptive
immune response to more eﬀectively clear the virus for
the following reasons. First, a signiﬁcant viral inhibitory
eﬀect was seen in the spinal cord at the same time as the
primary adaptive immune response to the virus had peaked6 Advances in Virology
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Figure 4: Flowchart demonstrating the potential mechanisms of 3Dpol antiviral eﬀect on viruses.
(7 days postinfection). If this reduction in viral load was
caused by a diﬀerence in adaptive immunity, then we would
not have expected to see a signiﬁcant diﬀerence in viral
loads until a few days after the primary adaptive immune
response had peaked. Second, the eﬀect of 3D polymerase
on viral infection was present in FVB-Db mice despite their
more eﬃcient viral immune system. To further test the
theory that 3D was not working via the adaptive immune
response, we crossed the 3D transgenic mice to FVB mice
that had the Rag 1 gene knocked out (FVB-Rag−/−). These
mice are completely void of T and B cells. FVB-Rag−/−
mice containing the 3D transgene had 10-fold less virus
14 days after infection with TMEV and lived longer than
nontransgenic FVB-Rag−/− mice. Although, we do not know
whether a change in the adaptive immune system provides
an additive eﬀect to support what we saw in 3D transgenic
mice, this data strongly indicates that the adaptive immune
system was not the primary reason for the viral inhibition by
transgenic 3D polymerase.
It is known that the random integration of transgenes
could aﬀect genes adjacent to the insertion site by disrupt-
ing the coding frame of a gene or disrupting regulatory
sequences of a gene(s). Pathology data at the 45-day-time
point showed that a second 3D transgenic mouse line had
even more signiﬁcant reduction in spinal cord pathology
thantheoriginalline,whichruledoutany“insertionaleﬀect”
from the random integration of the transgene itself.
To understand the possible mechanisms for which 3D
may be working we developed a ﬂow diagram as to the
possible places that 3D may function as an antiviral protein
(Figure 4). Transgenic 3D may interact directly through the
virus itself as it enters the cell. As mentioned previously,
3D oligomerizes with itself and can form a lattice of 3D
molecules. 3D also binds and interacts with many other
viral proteins and RNA. Transgenic 3D may be processed
diﬀerently in the host cell disrupting one or more binding
motifs that are important in interacting with other viral
molecules. Therefore, transgenic 3D could act as a dominant
negative form of the viral 3D thus competing for or interfer-
ing with binding sites. The function or folding structure of
the transgenic 3D molecule has not been studied making this
hypothesis plausible. Also, new data from viral transcripts
measured in mice infected with EMCV, another picornavirus
very similar to TMEV, showed similar viral inhibitory eﬀects,
which provided more evidence to support this hypothesis.
After infection of both 3D transgenic and nontransgenic
wild-type mice with 40 PFU of EMCV intraperitoneally, 3D
transgenic mice had 1000 fold less viral transcripts in the
brainandspinalcordjust3daysafterinfection(Figure 5(a)).
However, evidence against a direct dominant negative eﬀect
of 3D was found later. Data using a nonpicornavirus
indicate that 3D also has an antiviral eﬀect against viruses
other than picornaviruses. Because of its ability to infect
neurons, we infected mice with the pseudorabies virus
(PRV). PRV is a dsDNA alphaherpes virus that is tropic
to axon terminals and is transported retrogradely up the
neuron to the CNS. The virion does not encode an RNA-
dependent RNA-polymerase like 3D in its genome. After
infection with 2 × 107 PFU of PRV intramuscularly in the
hind limb, mice containing the 3D transgene had 100 fold
less virus 6 days after infection (Figure 5(b)). This indicated
that transgenic 3D polymerase has antiviral properties on
a broad spectrum of viruses and argues strongly against
a dominant negative eﬀect as the mechanism throughAdvances in Virology 7
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Figure 5: Viral load in mice infected with EMCV or PRV. (a) Viral transcripts in EMCV infected mice. Nontransgenic and 3D transgenic
FVB mice were infected with 40 plaque forming units of EMCV (VR-129B ATCC) intraperitoneally. Brain and spinal cord were harvested
after 3 days and total RNA was isolated using Trizol reagent (Invitrogen). Viral transcripts for EMCV were quantiﬁed by real-time PCR
using primers speciﬁc for the VP2 region of EMCV. Data were normalized to GAPDH transcripts and are expressed as mean relative viral
transcripts + SEM (n = 3 for nontransgenic and 4 for 3D transgenic). Data was statistically signiﬁcant using a two-tailed student’s t-test
assuming unequal variance. (b) Viral DNA in pseudorabies virus (PRV) infected mice. Nontransgenic and 3D transgenic FVB mice were
infected with 2 × 107 plaque forming units of PRV 152 intramuscularly in the left hind limb. Brain and spinal cord were harvested after 7
days and DNA was isolated. Viral DNA for PRV was quantiﬁed by real-time PCR using primers speciﬁc for the inserted EGFP in PRV 152.
Data are expressed as mean relative viral DNA (n = 2 for nontransgenic and 3 for 3D transgenic) and were normalized to genomic IL-2
DNA.
which 3D functions as an antiviral. Furthermore, stably
transfected cell lines, thus far, have failed to reproduce the
eﬀect seen in transgenic mice. Even if the function and
binding properties of the transgenic 3D were no diﬀerent
from viral 3D polymerase, a change in the stoichiometry
of the molecules in the cytoplasm may decrease the rate
of viral replication in picornaviruses. Studies have shown
that the stimulatory eﬀect of 3AB on 3D polymerization is
inhibited with increasing concentrations of 3D polymerase
in vitro [46–48]. However, this hypothesis suﬀers the same
arguments previously mentioned. Because of the ﬁnding
that transgenic 3D inhibits a dsDNA virus which does
not encode an RNA-dependent RNA-polymerase, we have
considered indirect mechanisms through which transgenic
3D may be functioning. Possible indirect mechanisms could
be that transgenic 3D is aﬀecting viral replication either
by regulating cell extrinsic factors such as Type I IFNs,
cell intrinsic factors such as host translational initiation
factors, or host RNA-binding factors that interact with viral
proteins or nucleotides. The expression of secreted proteins
that eﬀect the replication of the virus or innate immune
responses may be upregulated by 3D. Type I IFN’s are early
response cytokines of the innate immune system which are
important in controlling many viral infections [49, 50]. Up-
r e g u l a t i o no fT y p eII F N ’ si st r i g g e r e db yt h ep r e s e n c eo f
dsRNA in virally-infected cells. Therefore, we hypothesize
that the presence of functional transgenic 3D molecules
in the cytoplasm as the virus enters may allow dsRNA
synthesis to occur sooner, in contrast to viral replication
without transgenic 3D where transcription and processing
of all viral proteins in the viral genome has to occur before
RNA synthesis can take place. Earlier dsRNA synthesis may
theoretically lead to an accumulation of dsRNA molecules
in the cytoplasm which could then bind the appropriate
receptor to initiate transcription of type I IFN in infected
cells sooner when transgenic 3D is present. However, the
limitations to this are that many other viral proteins may
need to be transcribed and processed to form a replication
complex to allow eﬃcient RNA synthesis by transgenic 3D.
Another way transgenic 3D could up-regulate host proteins
is by replicating host mRNA transcripts which encode these
proteins. Previous studies showed that host transcription
is shut oﬀ through translocation of proteolytic 3CDpro
to the nucleus via a nuclear localization sequence located
near the N-terminus of the poliovirus 3D polymerase [51,
52]. Therefore, transgenic 3D itself may translocate to the
nuclease and theoretically replicate gene transcripts if the
right secondary structure is presented. Limitations of the
hypothesis for indirect mechanisms is the lack of scientiﬁc
literature to support the speciﬁc molecules needed for this
function. Therefore further investigation will be needed to
test this hypothesis. However, knowing that the antiviral
eﬀect seen in 3D transgenic mice occurs in both DNA and
RNA viruses, it is possible that this unexpected observation
will uncover new and interesting strategies for antiviral
research.
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